Avadel Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.41-$19.09 |
Market Cap | $1.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $95.1M |
Revenue Growth (YoY) | 2,674.3% |
Gross Profit (12 Mos) | $16.5M |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 3 months ago
Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent
Yahoo Finance • 7 months ago
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
Yahoo Finance • 8 months ago
11 Best Low Price Pharma Stocks To Invest In
About
CEO | Mr. Gregory J. Divis Jr. |
CFO | Mr. Thomas S. McHugh |
Address | 10 Earlsfort Terrace, Dublin, Ireland, 2 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 154 |
